研究と業績　2015年

研究と業績　2015年

英文

日野 雅之

  1. Nakane T, Tamura K, Hino M, Tamaki T, Yoshida I, Fukushima T, Tatsumi Y, Nakagawa Y, Hatanaka K, Takahashi T, Akiyama N, Tanimoto M, Ohyashiki K, Urabe A, Masaoka T, Kanamaru A. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial. J Infect Chemother 21:16-22, 2015

川口 知哉

  1. Tomoya Kawaguchi, Masahiko Ando, and Akihito Kubo. Reply to G. Spitzer and M.A. Socinski, F. Zhou et al, and B. Biswas. J Clin Oncol 33: 526-527, 2015
  2. Shun-ichi Isa, Yu Kurahara, Satomi Yamamoto, Akihiro Tamiya, Naoki Omachi, Kazuhiro Asami, Kyouichi Okishio, Tomoki Utsumi, Norimasa Ito, Hyung-Eun Yoon, Akihide Matsumura, Shinji Atagi, and Tomoya Kawaguchi Molecular Analysis of Human Papillomavirus in Never-Smokers with Non-Small Cell Lung Cance, ONCOLOGY LETTERS 9: 927-929, 2015
  3. Masaru Watanabe, Tomoya Kawaguchi, Shun-ichi Isa, Masahiko Ando, Akihiro Tamiya, Akihito Kubo, Hideo Saka, Sadanori Takeo, Hirofumi Adachi, Tsutomu Tagawa, Seiichi Kakegawa, Motohiro Yamashita, Kazuhiko Kataoka, Yukito Ichinose, Yukiyasu Takeuchi, Kazuhiro Sakamoto, Akihide Matsumura, Yasuhiro Koh. Ultra-sensitive detection of the pretreatment EGFR T790M mutation in non-small-cell lung cancer patients with an EGFR-activating mutation using picodroplet digital PCR. Clinical Cancer Res 21, 3552-60, 2015
  4. Yoshikazu Hasegawa, Masahiko Ando, Makoto Maemondo, Satomi Yamamoto, Shun-ichi Isa, Hideo Saka, Akihito Kubo, Tomoya Kawaguchi, Minoru Takada, Rafael Rosell, Takayasu Kurata, Sai-Hong Ignatius Ou. The role of smoking status on the progression-free survival of non-small-cell lung cancer patients harboring activating epidermal growth factor (EGFR) mutations receiving first-line EGFR tyrosine kinase inhibitor. A meta-analysis of prospective randomized trials. TheOncologist 2015;20:1–9
  5. Sugitani A, Asai K, Kojima K, Eguchi Y, Kawaguchi T, Ohsawa M, Hirata K. Primary Pleural Synovial Sarcoma Treated with Pazopanib. Intern Med 54:2051-5, 2015
  6. Takehito Shukuya, Takeharu Yamanaka, Takashi Seto, Haruko Daga, Koichi Goto, Hideo Saka, Shunichi Sugawara, Toshiaki Takahashi, Soichiro Yokota, Hiroyasu Kaneda, Tomoya Kawaguchi, Seisuke Nagase, Tetsuya Oguri, Yasuo Iwamoto, Takashi Nishimura, Yoshihiro Hattori, Kazuhiko Nakagawa, Yoichi Nakanishi, Nobuyuki Yamamoto. Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised phase 3 study. Lancet Oncology in press
  7. Naoki Omachi, Tomoya Kawaguchi, Shigeki Shimizu, Tomohisa Okuma, Masanori Kitaichi, Shinzi Atagi, Hyungeun Yoon M., Akihide Matsumura Life-threatening and rapidly growing teratoma in the anterior mediastinum Internal Medicine in press
  8. Toshiya Maekura, Shigeki Shimizu, Tomoya Kawaguchi, Masahiro Morimoto, Tomohisa Okuma, Hideo Matsui, Tadaaki Eimoto, Shinji Atagi. Primary Intravascular Synovial Sarcoma of the Pulmonary Artery Masquerading as Intimal Sarcoma: Report of a case with favorable response to ifosfamide chemotherapy plus palliative radiation therapy Internal Medicine in press

光岡 茂樹

  1. Yoshimura N, Kudoh S, Mitsuoka S, Yoshimoto N, Oka T, Nakai T, Suzumira T, Matusura K, Tochino Y, Asai K, Kimura T, Kawaguchi T, Hirata K. Phase Ⅱ study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation. Lung Cancer 2015;90:65-70.

鈴村　倫弘

  1. Ota T, Tsukuda H, Tokunaga M, Nishida N, Hasegawa Y, Suzumura T, Fukuoka M.Catheter detachment. Oxf Med Case Reports 2015;2015:292-293.
  2. Toshiyuki N, Kimura T, Suzumura T, Yoshimoto N, Oka T, Yamamoto N, Matsuura K, Mitsuoka S, Asai K, Tochino Y, Yoshimura N, Kawaguchi T, Kudoh S, Matsuoka T, Ohsawa M, Hirata K. The macroscopic appearance of computed tomography-guided needle biopsy specimens correlates with tumor metastasis in non-small cell lung cancer. Osaka City Med J 2015;61:105-112.

吉村 成央

  1. Yoshimura N, Kudoh S, Mitsuoka S, Yoshimoto N, Oka T, Nakai T, Suzumura T, Matsuura K, Tochino Y, Asai K, Kimura T, Kawaguchi T, Hirata K. Phase II study of a combination regimen of gefitinib and pemetrexed as first-line treatment in patients with advanced non-small cell lung cancer harboring a sensitive EGFR mutation. Lung Cancer 90: 65-70, 2015

和文

日野 雅之

  1. 岡村浩史, 中根孝彦, 藤野恵三, 康　史郎, 吉村卓朗, 西本光孝, 林　良樹, 康　秀男, 中尾吉孝, 中前博久, 日野雅之. 骨髄異形成症候群の同種造血幹細胞移植後再発に合併した冷式自己免疫性溶血性貧血. 臨床血液 2015;56:412-417.

工藤 新三

  1. 工藤新三. 非小細胞肺がん. 編集委員会編集. 入門腫瘍内科学. 改訂第2版. 東京：篠原出版新社, 2015.pp.173-177.